BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16029968)

  • 1. Thrombosis in children with hematologic malignancies.
    Schobess R; Kempf-Bielack B; Schwabe D; Sträter R; Nowak-Göttl U
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E2. PubMed ID: 16029968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of thrombotic children with malignancy.
    Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
    Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
    Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration.
    Nowak-Göttl U; Heinecke A; von Kries R; Nürnberger W; Münchow N; Junker R
    Thromb Res; 2001 Aug; 103(3):165-72. PubMed ID: 11672578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolism in newborns, infants and children.
    Nowak-Göttl U; Kosch A; Schlegel N
    Thromb Haemost; 2001 Jul; 86(1):464-74. PubMed ID: 11487037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-related thrombosis in hematologic malignancies.
    Nadir Y; Hoffman R; Brenner B
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects on hemostatic function of drugs used in hematologic malignancies.
    Zakarija A; Kwaan HC
    Semin Thromb Hemost; 2007 Jun; 33(4):355-64. PubMed ID: 17525893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonstroke arterial thrombosis in children: Hacettepe experience.
    Balci YI; Unal S; Gumruk F; Cetin M; Ozkutlu S; Gurgey A
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):519-24. PubMed ID: 18685435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic complications in pediatric hematologic malignancies.
    Athale UH; Chan AK
    Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
    Tallman MS; Kwaan HC
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients.
    Abdelkefi A; Ben Romdhane N; Kriaa A; Chelli M; Torjman L; Ladeb S; Ben Othman T; Lakhal A; Guermazi S; Ben Hassen A; Ladeb F; Ben Abdeladhim A
    Bone Marrow Transplant; 2005 Nov; 36(10):885-9. PubMed ID: 16151418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of thrombosis in patients with hematologic malignancies.
    Piccioli A; Vianello F; Prandoni P
    Curr Hematol Rep; 2002 Sep; 1(1):79-83. PubMed ID: 12901128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilia and cancer.
    Horowitz N; Brenner B
    Pathophysiol Haemost Thromb; 2008; 36(3-4):131-6. PubMed ID: 19176986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis and acute lymphoblastic leukaemia.
    Payne JH; Vora AJ
    Br J Haematol; 2007 Aug; 138(4):430-45. PubMed ID: 17608766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolism in children.
    Nowak-Göttl U; Kosch A; Schlegel N; Salem M; Manco-Johnson M
    Curr Opin Hematol; 2002 Sep; 9(5):448-53. PubMed ID: 12172465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
    Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
    Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary thrombophilia in ethnic Omani patients.
    Pathare A; Al Kindi S; Al Haddabi H; Dennison D; Bayoumi R; Muralitharan S
    Am J Hematol; 2006 Feb; 81(2):101-6. PubMed ID: 16432849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.